- Preclinical study in female C57BL/6J mice using a supradural acid-injection model of dural hypersensitivity, with patch-clamp recordings from dural trigeminal ganglion neurons.
- The peripherally restricted cannabinoid PrNMI (5 µM) was compared with the CB1R agonist ACEA and the CB2R agonist RNB61, each coapplied with the acidic saline.
- PrNMI and ACEA prevented both initial and latent allodynia, while RNB61 did not, and CB1R or CB2R inverse agonists abolished PrNMI's preventive effect.
- The authors conclude that PrNMI prevents acid-induced sensitization by coactivating neuronal CB1Rs and non-neuronal CB2Rs, and that its efficacy was lost once sensitization was established.
Latest papers
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Systematic review and meta-analysis of nine observational studies (n = 1,855) of patients receiving continuous-flow LVADs.
- No intervention was studied; vasoplegia after implantation was the exposure, assessed for incidence, predictors, and outcomes.
- Vasoplegia occurred in 34.2% of patients (95% CI 26.9%-42.4%) and was linked to higher early mortality, major bleeding, worse long-term survival, and longer stays.
- Male sex and higher BMI were predictors and higher blood pressure was protective, while ICU mortality, acute kidney injury, stroke, and right heart failure did not differ.
- Retrospective cohort of 31,979 singleton deliveries at or after 28 weeks across two Chicago hospitals, March 2018 to February 2020.
- Anemia was defined as third-trimester Hb below 11 g/dL and graded by severity, and was examined against sociodemographic factors and delivery site.
- Third-trimester anemia affected 40.2% (12,841 patients), more often in non-Hispanic Black patients (53.3%) and lower-income neighborhood residents.
- Transfusion was associated with Hispanic ethnicity (aOR 1.62), Asian race (aOR 1.42), anemia severity, cesarean delivery and site, but not non-Hispanic Black race (aOR 1.10).
- This case series describes two patients with isolated pseudoarticulation between lumbar transverse processes and the iliac crest, which the authors distinguish from Bertolotti's syndrome.
- Both patients received image-guided corticosteroid injection, and the second case used the same injection protocol as the first.
- The first patient had substantial, durable pain relief, while the second had significant but transient relief; the abstract reports no effect sizes or p values.
- The authors suggest this pain source may be under-recognized and that injections could help with localization and prognostication.
- Prospective single-arm pilot trial in consecutive patients with chronic postsurgical pain after total knee arthroplasty; 5 of 15 screened patients completed the study.
- Patients received cooled radiofrequency ablation (Coolief system), with change in NRS pain score from baseline to 6 months as the primary endpoint.
- The NRS change did not reach statistical significance at 6 months, though responder analysis showed a substantial proportion with clinically meaningful improvement; the KSS trend was also nonsignificant.
- No adverse events were reported, and the authors conclude the approach appears safe and potentially effective, with larger studies needed.
- This narrative review summarizes evidence on GLP-1 receptor agonist delayed gastric emptying and proposes a pharmacist-led perioperative risk framework.
- GLP-1 receptor agonists may leave residual gastric contents despite standard fasting, yet outcome studies have not consistently shown more aspiration pneumonia.
- These aspiration findings are limited by rare events, mostly retrospective designs, residual confounding, and inconsistent definitions of residual gastric contents.
- The proposed pathway covers medication verification, symptom screening, risk phenotyping, selective gastric ultrasound, and restart planning, and the authors call for prospective testing.
- Preclinical study in male rats with tibial-sparing nerve injury, where SCS responders and nonresponders were classified by how much SCS reduced mechanical hypersensitivity.
- Nonresponders received a subtherapeutic dose of the selective A3 adenosine receptor agonist 2-Cl-IB-MECA alone or combined with acute or repeated SCS.
- The low-dose agonist alone produced minimal pain inhibition, but combined with SCS it restored analgesic responses to both acute and repeated stimulation.
- Repeated SCS reduced microglial activation and shifted microglia toward an anti-inflammatory phenotype, suggesting persistent microglial activation may contribute to SCS nonresponsiveness.
- Systematic review and meta-analysis of 13 studies (12 retrospective cohorts, 1 multicenter RCT) covering 1,030,883 surgical patients, 16.6% of whom had intraoperative handover.
- Compared patients with versus without intraoperative anesthesia handover on postoperative morbidity and mortality; the exploratory pooled analysis included 7 studies with 485,623 patients.
- The pooled composite morbidity and mortality outcome was not significantly associated with handover (aOR 1.04; 95% CI 0.98-1.11; P = 0.18; I² = 72%).
- Authors found no consistent independent association, but heterogeneity and residual confounding limit causal interpretation; the RCT found no significant effect on 30-day outcomes.
- Randomized, sham-controlled, double-blind trial of 94 adults with chronic neuropathic pain, with responders and nonresponders followed in later parts.
- Five days of prolonged continuous theta burst stimulation (pcTBS), 10-Hz rTMS, or sham over left M1; nonresponders then received left DLPFC stimulation.
- Both active M1 groups reduced pain from baseline (10-Hz 37.9 ± 17.5 vs 48.5 ± 16.0, P < .001; pcTBS 35.1 ± 15.3 vs 47.1 ± 15.1, P < .001), with no difference between them (P = .16).
- pcTBS produced faster corticospinal excitability changes than sham (MEP 188.5 ± 39.8 vs 102.2 ± 6.9, P = .044). The authors conclude pcTBS is comparable to 10-Hz rTMS with substantially less treatment time.
- Retrospective cohort of 147 women aged 65 or older undergoing modified radical mastectomy: 78 received PSPB plus serratus anterior blocks, and 69 had no regional anesthesia.
- At 6 months, the block group had lower QuickDASH scores (7.8 vs 18.7, p<0.001) and better flexion and abduction, but Constant-Murley scores did not differ (p=0.682).
- Persistent stiffness occurred less often with blocks (42.3% vs 69.6%, p=0.002), and regional blockade was an independent protective factor (OR 0.29, 95% CI 0.14-0.59, p=0.001).
- The authors describe an association between regional anesthesia and better functional recovery but state that causality cannot be established given the retrospective design.
- A descriptive comparative study of three open-access ICU databases (MIMIC-IV, eICU-CRD, AmsterdamUMCdb) assessed their suitability for AI-based sepsis research.
- The authors used structured queries and manual semantic inspection to assess completeness, terminology, structure, and redundancy, focusing on antimicrobial administration and mortality markers.
- MIMIC-IV had 49% missing medication route and 58% missing dose, AmsterdamUMCdb had 61.4% of admissions without diagnosis, and eICU-CRD had 1.9% lacking diagnosis.
- The authors conclude these databases show substantial missingness, redundancy, and semantic variability, and none had reliable sepsis diagnosis timestamps, so rigorous preprocessing and standardized data collection are needed.
AI summary not available. Read the source abstract on PubMed.
- Secondary longitudinal mediation analysis of a 3-arm randomized trial (N = 223) in chronic low back pain, pooling 8-session CBT and 1-session Empowered Relief versus 1-session health education.
- Latent growth curve models tested whether changes in pain intensity, interference, catastrophizing, and self-efficacy over 3 months mediated improvements in sleep.
- Reductions in pain interference and catastrophizing were linked to indirect pathways to better sleep, while pain intensity was not, and self-efficacy showed a partial pathway.
- The authors suggest that targeting pain interference and pain-related cognitions may produce benefits across both sleep and pain; the abstract reports no effect sizes or confidence intervals.
- Case-control MRI study comparing 40 patients with non-specific chronic spinal pain against 60 controls, examining gray and white matter structure.
- Gray matter morphometry from T1-weighted images and white matter diffusion measures from diffusion-weighted imaging were compared between the two groups.
- Patients had significantly reduced gray matter volume in several pain processing and modulation regions, and increased mean and axial diffusivity in a few white matter regions.
- Imaging measures correlated with clinical scores, which the authors interpret as reflecting worse physical and mental health.
- Within-subject fMRI study of 31 participants comparing watch, cognitive reappraisal, and action simulation conditions during vicarious pain.
- Cognitive reappraisal and action simulation were each compared against passive watching during vicarious pain ratings.
- Both strategies reduced vicarious pain ratings, with reappraisal giving stronger regulation but longer response times; the abstract gives no effect sizes or p values.
- Authors propose a dual-pathway model in which action simulation is a less cognitively demanding route, with a sensorimotor link between left dmPFC and postcentral gyrus.
- Registry cohort of 22,771 patients from the Swedish Quality Registry for Pain who underwent interdisciplinary pain rehabilitation between 2016 and 2023.
- Deterioration was assessed with the Reliable Change Index across 18 patient-reported measures at the end of rehabilitation, with no comparator group.
- About 23% of patients had reliable deterioration on at least one measure, most often physical and pain-related measures, and 44.5% had mild deterioration on at least one measure.
- The authors conclude that negative short-term outcomes are common enough to warrant identifying affected patients and investigating the mechanisms behind them.
- Psychometric validation study of 536 children and adolescents aged 8-18 recruited from three hospital units in Spain, with a 50-participant retest subsample at 3 months.
- No intervention was tested; the Spanish 11-item Tampa Scale of Kinesiophobia (TSK-11) was compared against measures of pain intensity, interference, catastrophizing, pain anxiety, and physical functioning.
- Internal consistency was good (α=.88 total), test-retest reliability was excellent (ICC=.89), and confirmatory factor analysis supported the expected two-factor structure.
- Youth with chronic pain (M=24.70) and chronic post-surgical pain (M=27.81) scored higher than those without chronic pain (M=22.89), with correlations of r=.55 to .63 with related constructs.
- Retrospective single-center observational study of 60 patients with pancreatic cancer pain who received fluoroscopy-guided celiac plexus block, split into CPB-only (n = 34) and CPB plus botulinum toxin A (n = 26) groups.
- The comparison was CPB with BTX versus CPB alone, with pain (NRS), opioid use (MME), and rescue interventions tracked at 4, 8, and 12 weeks.
- The 4-week positive responder rate was 65.4% with BTX versus 8.8% without (p < 0.001), and BTX was independently associated with treatment success (OR = 20.75, p < 0.001).
- The authors conclude BTX may be a non-destructive adjunct to CPB, with no serious adverse events reported, and call for prospective validation.
- Secondary analysis of the no-intervention control group of the WalkBack trial, including 301 adults with low back pain who had recovered from an episode, followed for 12 months.
- Fifteen candidate prognostic factors were measured at baseline, and disability was self-reported at 3, 6, 9 and 12 months using the Roland-Morris Disability Questionnaire, summarised as an area under the curve.
- Higher body mass index (β = 0.27, 95% CI 0.04-0.49), worse previous pain intensity (β = 1.10, 95% CI 0.28-1.92), higher perceived recurrence risk (β = 0.71, 95% CI 0.14-1.28) and depressive symptoms (β = 0.61, 95% CI 0.18-1.05) were associated with greater 12-month disability burden.
- Each factor had a small, unique effect, and the authors suggest these findings may inform risk assessment and prevention of future disability after apparent recovery.
- A prospective observational study of 85 infants and children aged over 1 month to 6 years undergoing elective surgery under general anesthesia with orotracheal intubation.
- Ventilation was delivered with an endotracheal tube tip placed in the hypopharynx, performed by clinical anesthesia residents, and assessed for efficacy and safety without a comparator group.
- Successful ventilation, judged by chest rise, sustained capnography, stable saturation, and adequate tidal volume, occurred in 82 patients (96.5%), with no difference between resident groups (p = 0.407).
- Stomach insufflation occurred in 3 patients (3.5%), and severe hypoxemia, bradycardia, and laryngospasm were not observed; the authors suggest future trials compare it with facemasks or supraglottic devices.
- Single-center randomized trial of 98 adults undergoing elective unilateral total knee arthroplasty, with patients, surgeons, and outcome assessors blinded.
- Opioid-sparing anesthesia built on esketamine and dexmedetomidine was compared with conventional opioid-based anesthesia, and both groups had a femoral nerve block and multimodal analgesia.
- At 24 hours, QoR-15 was higher with opioid-sparing anesthesia (118.4 vs 113.3; adjusted difference 5.12, 95% CI 0.51-9.74; P=0.029), and this persisted at 48 hours.
- The authors concluded the strategy improved early QoR-15 scores, but the difference did not reach the minimal clinically important difference; lower PONV, lower CRP, and better 1-month Oxford Knee Score were also reported.
- This is a narrative review article in Otolaryngologic Clinics of North America, with no original study population or sample size reported.
- It describes how obesity may alter respiratory mechanics, upper airway stability, reflux, esophageal clearance, gastric emptying, and systemic inflammation.
- It covers voice, swallowing, reflux, airway mechanics, and perioperative and postoperative risks, aimed at laryngologists and general otolaryngologists.
- Prospective, open-label randomized trial of 105 adults aged 60 or older with moderate renal insufficiency undergoing elective OPCAB, split equally into three groups.
- Dexmedetomidine 0.4 μg/kg/h without a loading dose and dopamine 3 μg/kg/min were each compared with a normal saline control, infused from induction through 24 postoperative hours.
- Dexmedetomidine raised urine output (p < 0.01) and eGFR (p < 0.0001) versus dopamine and control at days 1 and 2; creatinine and BUN differences were not clinically significant.
- No group developed AKI by AKIN criteria, adverse events were similar across groups (p = 0.31), and the authors conclude neither drug prevented AKI beyond control.
- Retrospective cohort of 14,375 hip or knee arthroplasties, with 786 chronic GLP-1RA users propensity-matched 1:1 to 786 non-users.
- The exposure compared was chronic preoperative GLP-1RA therapy versus no GLP-1RA use.
- GLP-1RA use was not associated with lower inpatient opioid administration (adjusted difference -0.18; 95% CI -0.74 to 0.38; p=0.53) or with postoperative MME.
- GLP-1RA users had shorter length of stay (adjusted difference -10.41 hours; 95% CI -13.97 to -6.85; p<0.001), which the authors say needs prospective confirmation.
- Preclinical study using peripheral nerve injury models to examine PTP1B expression in dorsal root ganglion nociceptors.
- Investigators overexpressed and knocked down PTP1B in nociceptors, and tested Src and GluN2B inhibition on pain-like behavior and synaptic currents.
- Nerve injury sustainedly upregulated PTP1B, mainly in non-peptidergic nociceptors; overexpression produced neuropathic pain-like behaviors and knockdown reversed established hypersensitivity.
- The authors propose PTP1B as an upstream regulator of a presynaptic Src/GluN2B pathway and a potential therapeutic target for neuropathic pain.
- Cross-sectional bibliometric analysis of 4,982 original research papers (4,479 from high-income and 503 from low/middle-income countries) in ten top critical care journals, 2018 to 2022.
- Compared women's authorship by country income group, with stratification by funding type; no intervention was applied.
- Women held 31.3% of all authorships, 35.4% of first and 21.4% of senior positions, and representation was higher in low/middle-income countries overall (38.2% vs 30.6%; p < 0.01).
- The authors conclude that substantial gender disparity persisted, though women were better represented in low/middle-income country publications and authorship rose over time in both groups.
- Prospective documentation by research coordinators in an international stress ulcer prophylaxis trial in invasively ventilated patients, covering 5024 patients or substitute decision-makers approached for consent.
- Consent encounter features (consent model, who requested and gave consent, method) and center characteristics were analyzed with multilevel logistic regression; the trial itself had no intervention for this analysis.
- The overall consent rate was 85.0% (range 27.3% to 100%), with deferred consent associated with higher consent rates (OR 16.56; 95% CI 11.50-23.84).
- Consent rates were also higher when patients themselves were approached (OR 2.67; 95% CI 1.63-4.37) and during or after the COVID-19 pandemic, while center characteristics were not associated.
- Single-center, unadjusted retrospective cohort of 113 consecutive open TAAA repairs, comparing 86 prebundle patients with 27 patients managed under the BARTAAAKI bundle.
- The intervention was a perioperative renal protection bundle, a modified KDIGO-based protocol, compared with the prebundle period.
- Stage 2-3 AKI at 72 hours was less frequent after the bundle (56% vs 80%; risk difference -25 points, 95% CI -44 to -5; p = 0.02), and renal recovery at discharge was more frequent (93% vs 69%; +24 points, 95% CI +6 to +36; p = 0.01).
- Renal replacement therapy did not differ significantly (41% vs 52%; p = 0.38), and the authors call for prospective confirmation of these unadjusted findings.
- Cross-sectional study of 500 consecutive patients with type 2 diabetes, grouped by standard treatment, SGLT2 inhibitors, or GLP-1 receptor agonists.
- GLP-1 RA treatment was compared with standard care and SGLT2 inhibitors, with DPN assessed by examination, nerve conduction, and skin biopsy when indicated.
- After adjustment, GLP-1 RA use was associated with lower odds of DPN (OR 0.60, 95% CI 0.37-0.96) and painful DPN (OR 0.32, 95% CI 0.15-0.65).
- Unadjusted DPN rates were 46.4% vs 60.6% and painful DPN 10.1% vs 35.1% versus standard care; authors call for longitudinal studies.
- Single case report of a 37-year-old woman at 36 weeks with preeclampsia with severe features and acute cardiopulmonary failure.
- Venoarterial ECMO was started as a bridge to cesarean delivery without systemic anticoagulation, and delivery began once target flow was reached.
- Ejection fraction was below 20%; cardiac function recovered over 48 hours, support was stopped on day 3, and she left intensive care on day 9.
- The authors support individualized delivery timing and venoarterial ECMO as rescue support in selected critically unstable patients.
- This structured narrative review searched MEDLINE, Embase, Scopus and Web of Science through November 2025, supplemented by public health alerts, toxicology reports and drug-checking data.
- Drug-laced vaping delivers non-nicotine psychoactive substances such as cannabinoids, stimulants, opioids and benzodiazepines, sometimes without the user knowing, and routine toxicology may miss them.
- The authors group reported perioperative concerns into airway and lung injury, autonomic and cardiovascular instability, and altered consciousness with ventilatory compromise.
- Emerging synthetic cannabinoids and designer benzodiazepines may evade immunoassays, and the authors offer pragmatic checklists for preoperative, intraoperative and postoperative care.
AI summary not available. Read the source abstract on PubMed.
- A nationwide retrospective Taiwanese cohort study (2001-22) compared 247 pregnancy-associated ECLS cases with about 3.97 million non-ECLS pregnancies and 2,112 nonpregnant women receiving ECLS.
- The main exposure was ECLS during pregnancy or the peripartum period, with amniotic fluid embolism and peripartum cardiomyopathy as leading indications.
- Maternal 42-day mortality was 41.3%, and beyond 42 days ECLS-exposed pregnancies had higher all-cause mortality (aHR 28.0, 95% CI 16.8-46.8) than non-ECLS pregnancies.
- The authors conclude that pregnancy-associated ECLS is rare but rising, and that survivors need multidisciplinary follow-up for cardiovascular, renal and psychiatric sequelae.
- Randomized controlled murine study comparing control, EMS, LPS, and EMS/LPS groups, with only three mice analyzed per group.
- Mice received intraperitoneal LPS (2 mg/kg), then 30 minutes of left hindlimb EMS 8 hours later, compared with LPS alone.
- Under LPS, EMS reduced gastrocnemius fiber cross-sectional area (680 ± 327 vs 991 ± 453 μm2; P < .0001) and increased Atrogin-1 and MuRF1 expression.
- The authors conclude EMS during systemic inflammation worsened atrophy alongside IL-6/STAT3-C/EBPδ activation, and the unstimulated contralateral limb showed similar atrophic changes.
AI summary not available. Read the source abstract on PubMed.
- In this mouse study, the authors developed a noninvasive breath test of oral-cecal transit time using unanesthetized, freely moving animals.
- Orally given 13C-mannitol is metabolized by cecal microbiota to exhaled 13CO2, measured by indirect calorimetry with real-time 13C/12C ratio analysis.
- Pharmacological validation showed sensitivity to delayed transit, including a pronounced semaglutide-induced delay in obese mice; the abstract gives no effect sizes.
- The authors describe the method as high-throughput and longitudinal, improving rigor and reproducibility, and useful for GI physiology and drug studies.
- Retrospective single-center review of 245 pediatric patients aged 18 or younger who had isolated liver transplantation between 2013 and 2021.
- Patients were grouped by extubation timing: 33 immediate intraoperative, 110 early within 24 hours, and delayed extubation after 24 hours as the comparator.
- The immediate and early extubation group had significantly shorter ICU and hospital stays than the delayed group, and no patients were reintubated.
- Age, preoperative care setting, and intraoperative regional anesthesia independently predicted successful early extubation, with a C-statistic of 0.82 (95% CI 0.77–0.88).
- Prospective quasi-randomized controlled trial of 109 patients with persistent pain after knee arthroplasty, assigned by procedure group to genicular nerve treatment.
- Compared conventional radiofrequency thermocoagulation (RFT) with chemical neurolysis using phenol of the genicular nerves.
- Phenol had lower NRS at 1 month (3.67 vs 4.09, p=0.015) and 6 months (5.02 vs 6.52, p<0.001); 6-month ≥50% improvement was 43.6% vs 18.5% (p=0.005).
- Authors conclude both treatments are effective for persistent post-arthroplasty pain, complications were similar (5.5% vs 3.7%), and phenol's short-term benefit needs long-term confirmation.
- This preclinical study used an LPS-induced inflammatory cognitive impairment model in mice, created by intracerebroventricular injection; the abstract does not report sample size.
- Mice received semaglutide alone or combined with the O-GlcNAc transferase inhibitor OSMI-1 and AKT-silencing adeno-associated viruses.
- Semaglutide reversed LPS-induced cognitive deficits and restored hippocampal O-GlcNAcylation, though the abstract reports no effect sizes or statistics.
- The authors conclude that semaglutide ameliorates perioperative neurocognitive disorder through AKT O-GlcNAcylation, AKT-mTOR activation, and downstream neuroprotection.
- This retrospective PearlDiver database study included 95,566 primary total shoulder arthroplasty patients, of whom 1,549 (1.62%) were GLP-1 receptor agonist users.
- GLP-1 users were compared with non-users after 10:1 exact matching on age, sex, Elixhauser index, diabetes, hypertension and overall obesity, with multivariable adjustment for remaining imbalances.
- After adjustment, no significant differences in medical or orthopaedic complications were found, while GLP-1 users had lower 90-day ED visit (OR 0.75; P < .01) and readmission (OR 0.71; P < .01) odds.
- The authors concluded GLP-1 use was not associated with worse outcomes and may be linked to lower healthcare utilisation, though obesity-class subgroup differences were not significant, likely due to small size.